| 摘要 |
Compounds that inhibit PI3Kδactivity, including compounds that selectively inhibit PI3Kδactivity, are disclosed. Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3Kδ) activity, and methods of treating diseases, such as disorders of immunity and inflammation in which PI3Kδplays a role in leukocyte function, using the compounds also are disclosed. |
